Showing results (231-240 of 541) with videos related to

Sort By:
Pageof 55
Liver Cancer|October 9, 2025
Conversion Therapy Based on TACE/HAIC-Based Treatment to Improve the Therapeutic Effect of Initially Unresectable Hepatocellular CarcinomaShuirong Lin, Zimin Song, Peizhe Chen, et al.
Liver Cancer|August 18, 2025
Non-Invasive Kupffer-CEUS Enhances the Accuracy of Focal Liver Lesions Diagnosis in Patients with Liver Cirrhosis or Fibrosis: A Prospective Multicenter Study from ChinaYunlin Li, Xiao-Ling Yu, Xiang Jing, et al.
Liver Cancer|January 29, 2026
Patterns and Prognostic Stratification of Recurrence after Thermal Ablation in Patients with Hepatocellular CarcinomaChi-Ping Tan, Teng-Yu Lee, I-Cheng Lee, et al.
Liver Cancer|August 1, 2025
A Newly Launched Nationwide Database Revealed Real-World Evidence on Systemic Therapy for Unresectable Hepatocellular Carcinoma in Japan: Hepatoma Registry of Integrating and Aggregating Electronic Health Record (HERITAGE)Yoshinari Asaoka, Ryosuke Tateishi, Yasuhide Yamada, et al.
Liver Cancer|June 9, 2025
Comparison of Gadoxetic Acid-Enhanced Liver Magnetic Resonance Imaging and Contrast-Enhanced Computed Tomography for the Noninvasive Diagnosis of Hepatocellular CarcinomaJeong Hee Yoon, Won Chang, Young Kon Kim, et al.
Liver Cancer|June 11, 2025
The Concept of "Converse Therapeutic Hierarchy" for Patients with Hepatocellular CarcinomaAlessandro Vitale, Giuseppe Cabibbo, Lorenza Rimassa, et al.
Liver Cancer|June 13, 2025
Predicting Survival Outcomes in Patients with Hepatocellular Carcinoma Receiving Lenvatinib by Using the Up7-ALBI ScoreChien-Hung Lu, Wei-Yu Kao, Chih-Horng Wu, et al.
Liver Cancer|April 21, 2025
Consensus of Chinese Experts on Neoadjuvant and Conversion Therapies for Hepatocellular Carcinoma: 2023 UpdateXinyu Bi, Haitao Zhao, Hong Zhao, et al.
Liver Cancer|April 21, 2025
Particle Therapy for Intrahepatic Cholangiocarcinoma: A Multicenter Prospective Registry Study, Systematic Review and Meta-AnalysisMasashi Mizumoto, Kei Shibuya, Kazuki Terashima, et al.
Liver Cancer|March 27, 2025
Impact of Diabetes Mellitus and Obesity Comorbidities on Survival Outcomes after Hepatocellular Carcinoma Resection: A Multicenter Retrospective StudyHiroji Shinkawa, Masaki Kaibori, Masaki Ueno, et al.
Pageof 55